Cargando…
Cancer research: quo vadis—to war?
The notion that we should wage all-out war on cancer to break the back of the problem is considered fundamentally untenable because of the inherent nature of the disorder. An alternative is argued on the basis that we can only achieve a greater degree of control through attrition, since only a minor...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208922/ https://www.ncbi.nlm.nih.gov/pubmed/25374624 http://dx.doi.org/10.3332/ecancer.2014.ed45 |
_version_ | 1782341197205864448 |
---|---|
author | Wheatley, Denys |
author_facet | Wheatley, Denys |
author_sort | Wheatley, Denys |
collection | PubMed |
description | The notion that we should wage all-out war on cancer to break the back of the problem is considered fundamentally untenable because of the inherent nature of the disorder. An alternative is argued on the basis that we can only achieve a greater degree of control through attrition, since only a minority of tumour types might truly be curable in many cases. |
format | Online Article Text |
id | pubmed-4208922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-42089222014-11-05 Cancer research: quo vadis—to war? Wheatley, Denys Ecancermedicalscience Editorial The notion that we should wage all-out war on cancer to break the back of the problem is considered fundamentally untenable because of the inherent nature of the disorder. An alternative is argued on the basis that we can only achieve a greater degree of control through attrition, since only a minority of tumour types might truly be curable in many cases. Cancer Intelligence 2014-10-21 /pmc/articles/PMC4208922/ /pubmed/25374624 http://dx.doi.org/10.3332/ecancer.2014.ed45 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Wheatley, Denys Cancer research: quo vadis—to war? |
title | Cancer research: quo vadis—to war? |
title_full | Cancer research: quo vadis—to war? |
title_fullStr | Cancer research: quo vadis—to war? |
title_full_unstemmed | Cancer research: quo vadis—to war? |
title_short | Cancer research: quo vadis—to war? |
title_sort | cancer research: quo vadis—to war? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208922/ https://www.ncbi.nlm.nih.gov/pubmed/25374624 http://dx.doi.org/10.3332/ecancer.2014.ed45 |
work_keys_str_mv | AT wheatleydenys cancerresearchquovadistowar |